How One Gene Affects Alzheimer’s Risk - Science Friday Recap

Podcast: Science Friday

Published: 2026-02-25

Duration: 13 min

Summary

The episode delves into the significant role of the APOE gene in Alzheimer's disease risk, highlighting the distinctions between its variants and the potential for targeted therapies. Research indicates that a substantial percentage of Alzheimer's cases may be linked to medium and high-risk variations of this gene.

What Happened

In this episode of Science Friday, host Ira Flatow speaks with Dr. Dylan Williams, a Principal Research Fellow at University College London, about the genetic underpinnings of Alzheimer’s disease, focusing on the APOE gene. Dr. Williams explains that APOE plays a crucial role in transporting fats in the body and has various functions in the brain. Notably, the gene exists in three variants: E2, E3, and E4, with E4 being associated with a higher risk of developing Alzheimer’s. Dr. Williams emphasizes that understanding how these gene variants influence disease risk could pave the way for novel therapeutic approaches.

Dr. Williams shares insights from his research, indicating that between 70% to over 90% of Alzheimer's cases could not occur without the influence of the E3 and E4 gene variants. This finding is significant because it suggests that targeting these variants could substantially reduce the incidence of Alzheimer’s disease. He advocates for increased research and funding focused on these gene variants, arguing that they present a viable target for therapeutic development. The discussion also touches on the need for further studies to explore how the gene's role might differ across various ethnic groups and what other genetic and environmental factors may modify risks associated with Alzheimer’s.

Key Insights

• APOE gene variants E3 and E4 significantly influence Alzheimer's risk.
• 70-90% of Alzheimer's cases may be linked to these gene variants.
• Research on APOE has historically received less attention than it merits.
• Understanding the E2 variant's protective properties could inform prevention strategies.

Key Questions Answered

What role does the APOE gene play in Alzheimer's disease?

The APOE gene is known to have a significant impact on the risk of developing Alzheimer's disease. Dr. Williams explains that there are three forms of the gene: E2, E3, and E4, with E4 associated with a higher risk. The research indicates that the presence of E3 and E4 variants contributes to a large proportion of Alzheimer's cases, making it crucial to understand their effects on disease development.

How much of Alzheimer's risk is attributed to the APOE gene?

According to Dr. Williams, studies suggest that approximately 70 to 90% of Alzheimer's disease cases could be linked to the E3 and E4 variants of the APOE gene. This statistic highlights the gene's substantial role compared to other genetic factors, suggesting that targeting these specific variants could significantly reduce Alzheimer's incidence.

What are the implications of the E2 variant in Alzheimer's research?

The E2 variant of the APOE gene is associated with a lower risk of Alzheimer's disease, and understanding its properties is crucial. Dr. Williams mentions that only a small percentage of the population carries two copies of E2, making research into its protective mechanisms important. This could lead to new insights into prevention strategies and the safety of potential therapeutics.

How does the APOE gene's effect vary across different populations?

Dr. Williams points out that the research conducted so far has primarily focused on individuals of European ancestry, and it is essential to explore how the APOE gene's influence may differ in other ethnic groups. This understanding could uncover additional factors that either amplify or mitigate the effects of APOE on Alzheimer's risk.

What future research directions are suggested for Alzheimer's and the APOE gene?

The conversation emphasizes the need for continued research into the APOE gene, particularly its variants E3 and E4. Dr. Williams advocates for increased funding and efforts to understand how these genes contribute to Alzheimer's risk while also investigating other genetic and environmental factors that may influence the disease. This could lead to more targeted therapies and better prevention strategies.